Live Breaking News & Updates on A Stanford School Of Medicine

Stay updated with breaking news from A stanford school of medicine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Prominent Stanford University scientist and cellular reprogramming innovator will oversee all research for Turn Bio

Vittorio Sebastiano, globally recognized for pioneering science, expands his role at company he co-founded as it moves closer to clinical research MOUNTAIN VIEW, Calif., Aug. 8, 2022 /PRNewswire/ Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that co-founder Vittorio Sebastiano, PhD, will become its head of research. Sebastiano led development of the unique mRNA-based ERA (Epigenetic Reprogramming of Aging) platform Turn Bio uses to produce tailored protein cocktails to rejuvenate targeted cells. He assumes his role as head of research this month. Sebastiano has served as chairman of Turn Bio's Scientific Advisory Board since he co-founded the company in 2018. A Stanford School of Medicine faculty member, author of more than 50 scientific articles and frequent speaker at research conferences around the world, Sebastiano is prominent in the emerging field of cellular reprogramming. His ....

United States , Vittorio Sebastiano , Jim Martinez , Anja Krammer , A Stanford School Of Medicine , His Stanford University , American Federation For Aging Research , Glenn Foundation , Stanford Institute For Stem Cell Biology , Max Planck Institute For Molecular Biomedicine , Stanford Stem Cell Phd Program , Epigenetic Reprogramming , Turn Bio , Scientific Advisory Board , Stanford School , Stanford University , Max Planck Institute , Molecular Biomedicine , Stanford Institute , Stem Cell , Woods Family Scholar , Pediatric Medicine , Aging Research , Junior Investigator Award , Gerontology Award , Lobally Recognized For Pioneering Science ,

Stanford Med professor: Race-based priority for COVID vaccine could harm minorities

CDC advisory committee approves racial considerations over lives saved
Two Ivy League medical professors are facing backlash for recommending that COVID-19 vaccine distribution should be prioritized based on skin color rather than risk level.
The University of Pennsylvania’s Harald Schmidt and Harvard University’s Marc Lipsitch have since somewhat walked back their comments to
The New York Times, though Lipsitch claimed his views were misinterpreted.
Neither the professors nor their academic institutions responded to
College Fix requests for comment on the medical scholars’ stated views that predominantly white groups should not get vaccine priority.
Schmidt and Lipsitch were discussing the Advisory Committee on Immunization Practices’ pending recommendations to the CDC on which group should get vaccines first, “essential workers” or elderly people. ....

New York , United States , David Harsanyi , Marc Lipsitch , Penn Schmidt , Tucker Carlson , Peter Szilagyi , Coleman Hughes , Brennan Rose , Robert Redfield , Jay Bhattacharya , A Stanford School Of Medicine , Manhattan Institute , New York Times , Harvard University , Harvard University Marc Lipsitch , Ivy League , Foundation For Research On Equal Opportunity , University Of Pennsylvania , University Of Pennsylvania Harald Schmidt , Stanford University , College Fix , Advisory Committee On Immunization Practices , Harald Schmidt , Advisory Committee , Immunization Practice ,